Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
Chargers suffer major blow as star left tackle Rashawn Slater sustains season-ending injury, forcing roster adjustments and raising concerns about the team's prospects.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
Chargers suffer major blow as star left tackle Rashawn Slater sustains season-ending injury, forcing roster adjustments and raising concerns about the team's prospects.